Abstract
Background
Benign Prostatic Obstruction (BPO) is the most common non-malignant urological condition among men and its incidence rise with age. Among prostate treatments, GreenLight laser seems to reduce bleeding and would be safer in the aging population.
Aims
We aimed to compare the functional outcomes and safety profile of < 75 years old (Group A) and ≥ 75 years old (Group B) patients.
Methods
In a multicenter setting, we retrospectively analyzed all the patients treated with GreenLight Laser vaporization of the prostate (PVP).
Results
1077 patients were eligible for this study. 757 belonged to Group A (median age 66 years) and 320 to Group B (median age 78 years). No differences were present between the two groups in terms of prostate volume, operative time, hospital stay, PSA decrease over time after surgery, complications and re-intervention rate with a median follow-up period of 18 months (IQR 12–26). Nevertheless, focusing on complications, GreenLight laser PVP demonstrated an excellent safety profile in terms of hospital stay, re-intervention and complications, with an overall 29.6% complication rate in older patients and only two cases of Clavien III. Functional outcomes were similar at 12 month and became in favor of Group A over time. These data are satisfactory with a Qmax improvement of 111.7% and an IPSS reduction of 69.5% in older patients.
Discussion and conclusions
GreenLight laser photoselective vaporization of the prostate is a safe and efficient procedure for all patients, despite their age, with comparable outcomes and an equal safety profile.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Launer BM, McVary KT, Ricke WA et al (2021) The rising worldwide impact of benign prostatic hyperplasia. BJU Int 127:722–728. https://doi.org/10.1111/bju.15286
Boudoulas KD, Triposkiadis F, Stefanadis C et al (2017) The endlessness evolution of medicine, continuous increase in life expectancy and constant role of the physician. Hellenic J Cardiol 58:322–330. https://doi.org/10.1016/j.hjc.2017.05.001
Pichon T, Lebdai S, Launay CP et al (2017) Geriatric assessment can predict outcomes of endoscopic surgery for benign prostatic hyperplasia in elderly patients. J Endourol 31:1195–1202. https://doi.org/10.1089/end.2017.0325
Onder G, Vetrano DL, Palmer K et al (2022) Italian guidelines on management of persons with multimorbidity and polypharmacy. Aging Clin Exp Res 34:989–996. https://doi.org/10.1007/s40520-022-02094-z
Aceto P, Antonelli Incalzi R, Bettelli G et al (2020) Perioperative management of elderly patients (prime): recommendations from an Italian intersociety consensus. Aging Clin Exp Res 32:1647–1673. https://doi.org/10.1007/s40520-020-01624-x
Manfredi C, Arcaniolo D, Spatafora P et al (2022) Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. Minerva Urol Nephrol 74:389–399. https://doi.org/10.23736/S2724-6051.21.04530-4
Sze C, Chughtai B, Kaplan SA (2022) I can’t get no satisfaction: patient-reported outcomes after different treatment options for lower urinary tract symptoms. Eur Urol Focus 8:377–379. https://doi.org/10.1016/j.euf.2022.03.002
Franco JV, Jung JH, Imamura M et al (2021) Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis. Cochrane Database Syst Rev 7:CD013656. https://doi.org/10.1002/14651858.CD013656
Wang YB, Yan SY, Xu XF et al (2021) Comparison on the efficacy and safety of different surgical treatments for benign prostatic hyperplasia with volume >60 mL: a systematic review and bayesian network meta-analysis of randomized controlled trials. Am J Mens Health 15:15579883211067086
Wei HB, Guo BY, Tu YF et al (2022) Comparison of the efficacy and safety of transurethral laser versus open prostatectomy for patients with large-sized benign prostatic hyperplasia: a meta-analysis of comparative trials. Investig Clin Urol 63:262–272. https://doi.org/10.4111/icu.20210281
Taratkin M, Shpikina A, Morozov A et al (2021) Enucleation vs vaporization of benign prostatic hyperplasia: a head-to-head comparison of the various outcomes and complications. A systematic review and meta-analysis. Minerva Urol Nephrol. https://doi.org/10.23736/S2724-6051.21.04639-5
Campobasso D, Ferrari G, Frattini A (2022) GreenLight laser: a laser for every prostate and every urologist. World J Urol 40:295–296. https://doi.org/10.1007/s00345-020-03499-z
Meskawi M, Hueber PA, Valdivieso R et al (2019) Complications and functional outcomes of high-risk patient with cardiovascular disease on antithrombotic medication treated with the 532-nm-laser photo-vaporization GreenLight XPS-180 W for benign prostate hyperplasia. World J Urol 37:1671–1678. https://doi.org/10.1007/s00345-018-2560-8
Hossack T, Woo H (2014) Validation of a patient reported outcome questionnaire for assessing success of endoscopic prostatectomy. Prostate Int 2:182–187. https://doi.org/10.12954/PI.14066
Cindolo L, De Nunzio C, Greco F et al (2018) Standard vs. anatomical 180-W GreenLight laser photoselective vaporization of the prostate: a propensity score analysis. World J Urol 36:91–97. https://doi.org/10.1007/s00345-017-2106-5
Burtt G, Springate C, Martin A et al (2022) The efficacy and safety of laser and electrosurgical transurethral procedures for the treatment of BPO in high-risk patients: a systematic review. Res Rep Urol 14:247–257. https://doi.org/10.2147/RRU.S361956
Campobasso D, Marchioni M, Altieri V et al (2020) GreenLight photoselective vaporization of the prostate: one laser for different prostate sizes. J Endourol 34:54–62. https://doi.org/10.1089/end.2019.0478
Campobasso D, Marchioni M, De Nunzio C et al (2021) Predictors of re-intervention after greenlight laser photoselective vaporization of the prostate: multicenter long/mid-term follow-up experience. Mini-invasive Surg 5:45. https://doi.org/10.20517/2574-1225.2021.92
Nguyen DD, Deyirmendjian C, Law K et al (2022) GreenLight photovaporization of the prostate in high-medical-risk patients: an analysis of the Global GreenLight Group (GGG) database. World J Urol 40:1755–1762. https://doi.org/10.1007/s00345-022-03986-5
Cindolo L, Ruggera L, Destefanis P et al (2017) Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser. Int Urol Nephrol 49:405–411. https://doi.org/10.1007/s11255-016-1494-6
Tamalunas A, Westhofen T, Schott M et al (2021) The clinical value of holmium laser enucleation of the prostate in octogenarians. LUTS Low Urin Tract Symp 13:279–285. https://doi.org/10.1111/luts.12366
Heiman J, Agarwal D, Komanapalli S et al (2022) Outcomes of octogenarians undergoing holmium laser enucleation of prostate. World J Urol 40:1751–1754. https://doi.org/10.1007/s00345-022-04053-9
Anan G, Iwamura H, Mikami J et al (2021) Efficacy and safety of holmium laser enucleation of the prostate for elderly patients: surgical outcomes and King’s Health Questionnaire. Transl Androl Urol 10:775–784. https://doi.org/10.21037/tau-20-1309
Castellani D, Di Rosa M, Pace G et al (2021) Comparison between thulium laser vapoenucleation and plasmakinetic resection of the prostate in men aged 75 years and older in a real-life setting: a propensity score analysis. Aging Clin Exp Res 33:1757–1763. https://doi.org/10.1007/s40520-021-01868-1
Bertolo R, Vittori M, Cipriani C et al (2021) Is thulium laser vapoenucleation of the prostate equally safe and effective in elderly patients? A propensity score matched analysis of early perioperative and functional outcomes. Actas Urol Esp (Engl Ed) 45:648–655. https://doi.org/10.1016/j.acuroe.2020.09.011
Liu X, Yuan F, Xue MdB (2020) GreenLight XPS 180-W laser vaporization of prostate in high-risk elderly patients: a single-center experience. Photobiomodul Photomed Laser Surg 38:380–384. https://doi.org/10.1089/photob.2019.4735
Moiroud M, Ait Said K, Vaudreuil L et al (2019) Prostate laser photovaporization in older people with and without bladder catheter. J Am Geriatr Soc 67:1888–1894. https://doi.org/10.1111/jgs.16019
Taylor JA 3rd, Kuchel GA (2006) Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc 54:1920–1932. https://doi.org/10.1111/j.1532-5415.2006.00917.x
Valdivieso R, Meyer CP, Hueber PA et al (2016) Assessment of energy density usage during 180 W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate? BJU Int 118:633–640. https://doi.org/10.1111/bju.13479
Campobasso D, Acampora A, De Nunzio C et al (2021) Post-operative acute urinary retention after GreenLight laser. Analysis of risk factors from a multicentric database. Urol J 18:693–698. https://doi.org/10.22037/uj.v18i.6489
Funding
None.
Author information
Authors and Affiliations
Contributions
Conceptualization, Methodology, Writing—original draft preparation: DC; Methodology, Writing—original draft preparation, Formal analysis: SM; Material preparation, data collection: FG, PD, GF, FV, SV, GR, TC, RO, AT, LR, AL, CD, PG, GD, LP, MC, FM, SR, RM, LS, AF; Supervision: CD, GF, SM; Conceptualization, Methodology, review and editing: LC.
Corresponding author
Ethics declarations
Conflict of interest
P.D., L.R., C.D., G.F., and L.C. do surgical tutorship for AMS and received honoraria for their tutorship. All other authors have no competing financial interests that exist.
Human and animal rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.
Ethical approval
Ethical approval was waived by the local Ethics Committee of the University of Chieti in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Campobasso, D., Morselli, S., Greco, F. et al. Efficacy and safety profile of GreenLight laser photoselective vaporization of the prostate in ≥ 75 years old patients: results from the Italian GreenLight Laser Study Group. Aging Clin Exp Res 35, 877–885 (2023). https://doi.org/10.1007/s40520-023-02351-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-023-02351-9